Loading
Latest filing published 22 Apr 2021 for GenMark Diagnostics, Inc., €1.3M.
No signal scores available.
Abdul Chohan appears in our data through filings on GenMark Diagnostics, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 18 February 2021 to 22 April 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 22 April 2021: a transaction of €1.3M, in GenMark Diagnostics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations